ILB2109
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ILB2109, covering 2024-05-21 to 2024-11-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ILB2109 in Patients With Advanced Solid Malignancies [Phase 1]